Quanterix Corporation (QTRX) Decreased to All-Time Low at $13.95 on Jun, 29

June 29, 2018 - By Bridget Boland

On Jun, 29, all time low was touched by Quanterix Corporation (NASDAQ:QTRX). Today’s share price was $13.95. It’s 4.00 % below our $13.39. Barchart.com reported this technical pattern. Quanterix Corporation (NASDAQ:QTRX) has $306.34 million MC. At $13.39 stock target, the company valuation changes by $12.25 million less.

The stock decreased 0.92% or $0.13 during the last trading session, touching $13.95.Quanterix Corporation has volume of 46,443 shares. Since June 29, 2017 QTRX has 0.00% and is . QTRX underperformed the S&P 500 by 12.57%.

Quanterix Corporation (NASDAQ:QTRX)’s earnings report is anticipated on August, 21., as reported by RTT. Wall Street now predicts -15.15 % EPS growth despite Quanterix Corporation previous quarter’s EPS of $-0.33.

For more Quanterix Corporation (NASDAQ:QTRX) news published briefly go to: Seekingalpha.com, Businesswire.com, Benzinga.com, Benzinga.com or Benzinga.com. The titles are as follows: “Stocks To Watch: Eyes On Apple’s WWDC, SCOTUS And DC” published on June 02, 2018, “EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of …” on June 13, 2018, “The Week Ahead: Apple’s Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs” with a publish date: June 04, 2018, “35 Stocks Moving In Tuesday’s Mid-Day Session” and the last “45 Biggest Movers From Yesterday” with publication date: June 06, 2018.

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific.The firm is worth $306.34 million. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test.Currently it has negative earnings. The company's products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips.

Quanterix Corporation (NASDAQ:QTRX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.